Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Rheumatology
Volume 2014, Article ID 679580, 4 pages
http://dx.doi.org/10.1155/2014/679580
Case Report

Methotrexate Induced Pancytopenia

1Department of Internal Medicine, Mount Sinai School of Medicine, Jersey City Medical Center, 355 Grand Street, Jersey City, NJ 07302, USA
2 Department of Internal Medicine, Jersey City Medical Center, St. George’s University School of Medicine, Jersey City, NJ 07302, USA
3Laureate National Institute of Medicine, Jersey City Medical Center, 355 Grand Street, Jersey City, NJ 07302, USA
4Department of Hematology, Mount Sinai School of Medicine, Jersey City Medical Center, Jersey City, NJ 07302, USA
5Department of Rheumatology, Mount Sinai School of Medicine, Jersey City Medical Center, Jersey City, NJ 07302, USA

Received 17 March 2014; Accepted 15 May 2014; Published 27 May 2014

Academic Editor: Geoffrey Owen Littlejohn

Copyright © 2014 Fernando Gonzalez-Ibarra et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. W. Simms, C. K. Kwoh, L. G. Anderson et al., “Guidelines for monitoring drug therapy in rheumatoid arthritis: American College of Rheumatology Ad Hoc Committee on Clinical Guidelines,” Arthritis and Rheumatism, vol. 39, no. 5, pp. 723–731, 1996. View at Google Scholar · View at Scopus
  2. S. Gutierrez-Urena, J. F. Molina, C. O. Garcia et al., “Pancytopenia secondary to MTX therapy in rheumatoid arthritis,” Arthritis and Rheumatism, vol. 39, pp. 272–276, 1996. View at Google Scholar
  3. A. C. Cannella and J. R. O'dell, “Traditional DMARDs: methotrexate, leflunomide, sulfasalazine, hydroxychloroquine, and combination therapies,” in Kelley's Textbook of Rheumatology, chapther 61, Elsevier Saunders, Philadelphia, Pa, USA, 9th edition, 2012. View at Google Scholar
  4. E. Beutler and W. J. Williams, Williams Hematology, McGraw-Hill, New York, NY, USA, 2010.
  5. L. Brunton, B. Chabner, and B. Knollman, Goodman and Gilman's the Pharmacological Basis of therapeutics, McGraw-Hill, New York, NY, USA, 12th edition, 2013.
  6. A. N. Colebatch, J. L. Marks, and C. J. Edwards, “Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis),” Cochrane Database of Systematic Reviews, no. 11, Article ID CD008872, 2011. View at Google Scholar · View at Scopus
  7. J. M. Kremer and R. A. Hamilton, “The effects of nonsteroidal antiinflammatory drugs on methotrexate (MTX) pharmacokinetics: Impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5 mg,” Journal of Rheumatology, vol. 22, no. 11, pp. 2072–2077, 1995. View at Google Scholar · View at Scopus
  8. S. L. Morgan, J. E. Baggott, W. H. Vaughn et al., “Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial,” Annals of Internal Medicine, vol. 121, no. 11, pp. 833–841, 1994. View at Google Scholar · View at Scopus
  9. S. Bar-Yehuda, M. H. Silverman, W. D. Kerns, A. Ochaion, S. Cohen, and P. Fishman, “The anti-inflammatory effect of A3 adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis,” Expert Opinion on Investigational Drugs, vol. 16, no. 10, pp. 1601–1613, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. R. A. Hamilton and J. M. Kremer, “Why intramuscular methotrexate may be more efficacious than oral dosing in patients with rheumatoid arthritis,” British Journal of Rheumatology, vol. 36, no. 1, pp. 86–90, 1997. View at Google Scholar · View at Scopus
  11. J. M. Kremer, G. S. Alarcón, R. W. Lightfoot Jr. et al., “Methotrexate for rheumatoid arthritis: suggested guidelines for monitoring liver toxicity,” Arthritis and Rheumatism, vol. 37, no. 3, pp. 316–328, 1994. View at Google Scholar · View at Scopus
  12. P. A. Andersen, S. G. West, J. R. O'Dell, C. S. Via, R. G. Claypool, and B. L. Kotzin, “Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study,” Annals of Internal Medicine, vol. 103, no. 4, pp. 489–496, 1985. View at Google Scholar · View at Scopus
  13. M. E. Weinblatt, H. Kaplan, B. F. Germain et al., “Methotrexate in rheumatoid arthritis: a five-year prospective multicenter study,” Arthritis and Rheumatism, vol. 37, no. 10, pp. 1492–1498, 1994. View at Publisher · View at Google Scholar · View at Scopus
  14. H. J. Williams, R. F. Willkens, C. O. Samuelson Jr. et al., “Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial,” Arthritis and Rheumatism, vol. 28, no. 7, pp. 721–730, 1985. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Dalrymple, L. Stamp, and J. O'Donnell, “Pharmacokinetics of oral Methotrexate in patients with rheumatoid arthritis,” Arthritis and Rheumatism, vol. 58, pp. 3299–3308, 2008. View at Google Scholar
  16. J. Wegrzyn, P. Adeleine, and P. Miossec, “Better efficacy of methotrexate given by intramuscular injection than orally in patients with rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 63, no. 10, pp. 1232–1234, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. J. M. Kremer and J. K. Lee, “The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis,” Arthritis and Rheumatism, vol. 29, no. 7, pp. 822–831, 1986. View at Google Scholar · View at Scopus
  18. K. G. Saag, G. T. Gim, N. M. Patkar et al., “American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis,” Arthritis Care and Research, vol. 59, no. 6, pp. 762–784, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. A. E. Van Ede, R. F. Laan, M. J. Rood et al., “Effect of folic or folonic acid supplementation on the toxicity and efficacy of MTX in rheumatoid arthritis: a forty eight week, multicenter, randomized, double-blinded, placebo-controlled study,” Arthritis and Rheumatism, vol. 44, pp. 1515–1524, 2001. View at Google Scholar
  20. F. Bressolle, C. Bologna, J. M. Kinowski, B. Arcos, J. Sany, and B. Combe, “Total and free methotrexate pharmacokinetics in elderly patients with rheumatoid arthritis. A comparison with young patients,” Journal of Rheumatology, vol. 24, no. 10, pp. 1903–1909, 1997. View at Google Scholar · View at Scopus